A 2024 analysis of real-world tirzepatide use noted that menstrual irregularities peaked between weeks 412 of therapy and resolved in most patients by month 46
These may include chronic liver problems, diabetes, some lung diseases, and neurodegenerative disorders
It also upregulates growth factors, modulates inflammatory cytokines, activates FAK-paxillin signaling (which drives cell migration into injury sites), and supports collagen synthesis
It is not a prescription drug
Key limitation: Most injectable GHK-Cu dosage protocols are extrapolated from topical human trials and animal studies
Skin whitening targets dark patches, darker areas, dark spots, age spots, melasma, hyperpigmentation, and uneven skin tone